Therefore, we hypothesise that the reduction of C1QBP may cause mitochondrial damage, leading to compromised cellular function and the passive activation of HIF‐1α in tumour cells, ultimately enhancing glycolysis to compensate for the energy deficit. Here, C1QBP is linked to neoplasm.